Verus Financial Partners’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.13M Sell
4,453
-468
-10% -$109K 0.1% 45
2026
Q1
$1.15M Buy
4,921
+227
+5% +$52.9K 0.1% 42
2025
Q4
$1.04M Sell
4,694
-575
-11% -$114K 0.1% 47
2025
Q3
$977K Buy
5,269
+1,101
+26% +$189K 0.09% 45
2025
Q2
$651K Sell
4,168
-108
-3% -$16.6K 0.07% 50
2025
Q1
$657K Buy
4,276
+275
+7% +$43K 0.07% 48
2024
Q4
$568K Sell
4,001
-331
-8% -$51.3K 0.06% 49
2024
Q3
$702K Sell
4,332
-186
-4% -$29.6K 0.08% 46
2024
Q2
$660K Sell
4,518
-65
-1% -$9.67K 0.08% 45
2024
Q1
$725K Sell
4,583
-236
-5% -$37.6K 0.08% 44
2023
Q4
$769K Buy
4,819
+28
+0.6% +$4.29K 0.1% 42
2023
Q3
$752K Buy
4,791
+415
+9% +$68.5K 0.1% 40
2023
Q2
$754K Sell
4,376
-117
-3% -$18.9K 0.1% 43
2023
Q1
$728K Sell
4,493
-300
-6% -$48.4K 0.1% 43
2022
Q4
$783K Sell
4,793
-780
-14% -$135K 0.11% 43
2022
Q3
$925K Sell
5,573
-428
-7% -$72.4K 0.14% 35
2022
Q2
$1.03M Buy
6,001
+1,367
+29% +$244K 0.15% 34
2022
Q1
$834K Sell
4,634
-87
-2% -$14.8K 0.12% 38
2021
Q4
$808K Sell
4,721
-335
-7% -$54.8K 0.11% 40
2021
Q3
$810K Buy
5,056
+99
+2% +$16.9K 0.12% 38
2021
Q2
$835K Buy
4,957
+346
+8% +$57.3K 0.13% 36
2021
Q1
$754K Sell
4,611
-311
-6% -$50.3K 0.12% 36
2020
Q4
$775K Sell
4,922
-6,276
-56% -$926K 0.13% 34
2020
Q3
$1.67M Buy
11,198
+6,850
+158% +$1.01M 0.61% 28
2020
Q2
$611K Sell
4,348
-82
-2% -$11.9K 0.13% 32
2020
Q1
$581K Buy
4,430
+48
+1% +$6.81K 0.18% 30
2019
Q4
$639K Buy
4,382
+74
+2% +$10K 0.19% 33
2019
Q3
$557K Buy
4,308
+105
+2% +$13.8K 0.18% 28
2019
Q2
$585K Sell
4,203
-134
-3% -$18.5K 0.2% 26
2019
Q1
$606K Buy
4,337
+568
+15% +$76.1K 0.21% 24
2018
Q4
$521K Hold
3,769
0.19% 23
2018
Q3
$521K Sell
3,769
-230
-6% -$30.6K 0.19% 23
2018
Q2
$485K Sell
3,999
-12
-0.3% -$1.5K 0.18% 23
2018
Q1
$514K Buy
4,011
+200
+5% +$27K 0.19% 25
2017
Q4
$532K Buy
3,811
+85
+2% +$11.8K 0.19% 23
2017
Q3
$484K Sell
3,726
-36
-1% -$4.77K 0.19% 23
2017
Q2
$498K Sell
3,762
-45
-1% -$5.74K 0.2% 22
2017
Q1
$474K Sell
3,807
-388
-9% -$46.4K 0.19% 23
2016
Q4
$483K Buy
4,195
+4
+0.1% +$462 0.21% 22
2016
Q3
$495K Buy
4,191
+6
+0.1% +$728 0.22% 22
2016
Q2
$508K Sell
4,185
-611
-13% -$69.4K 0.23% 21
2016
Q1
$519K Sell
4,796
-268
-5% -$27.7K 0.24% 22
2015
Q4
$520K Buy
5,064
+195
+4% +$19.6K 0.25% 23
2015
Q3
$454K Buy
4,869
+47
+1% +$4.55K 0.24% 21
2015
Q2
$470K Buy
4,822
+13
+0.3% +$1.3K 0.24% 20
2015
Q1
$484K Sell
4,809
-81
-2% -$8.24K 0.25% 21
2014
Q4
$511K Sell
4,890
-264
-5% -$27.8K 0.27% 21
2014
Q3
$549K Buy
5,154
+14
+0.3% +$1.45K 0.31% 22
2014
Q2
$538K Sell
5,140
-22
-0.4% -$2.22K 0.3% 21
2014
Q1
$507K Buy
5,162
+115
+2% +$10.7K 0.28% 24
2013
Q4
$462K Buy
5,047
+14
+0.3% +$1.29K 0.24% 23
2013
Q3
$436K Buy
5,033
+22
+0.4% +$1.97K 0.24% 21
2013
Q2
$430K Buy
+5,011
New +$425K 0.24% 21

Other funds holding JNJ

Verus Financial Partners's JNJ Position: Q2 2026 in Review

Verus Financial Partners reduced its Johnson & Johnson (JNJ) stake by 9.5% in Q2 2026, selling an estimated $109K and leaving 4,453 shares worth $1.13M. The position accounts for 0.1% of the portfolio, ranked #45.

Verus Financial Partners first reported a position in JNJ in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.67M in Q3 2020. 2,379 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Verus Financial Partners held 4,453 shares of Johnson & Johnson worth $1.13M as of Q2 2026.
  • Verus Financial Partners sold 468 Johnson & Johnson shares in Q2 2026, an estimated $109K.
  • Johnson & Johnson made up 0.1% of Verus Financial Partners's portfolio in Q2 2026, its #45 holding.
  • Verus Financial Partners first reported a position in Johnson & Johnson in Q2 2013 and has held it in 53 quarters since.
  • Verus Financial Partners's Johnson & Johnson position peaked at $1.67M in Q3 2020.
  • 2,379 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Verus Financial Partners's 13F filing for Q2 2026, filed 21 Jul 2026.